Diabetes Options for Improved Outcomes  - CMEZ378

Diabetes Options for Improved Outcomes

by Susanne J. Pavlovich-Danis, MSN, RN, ARNP-C, CDE, CRRN and Michael George Danis, BSN, RN, CCRN
CMEZ378
(4.6 / 207 ratings )

This course is credentialed for:
Medicine (1.00 Credits)
Physician (1.00 Credits)

ONLINE
Price: $15.00
CE-PRO Price: $7.50

Summary:

Only 57% of people with diabetes have well-controlled blood glucose levels. For some people with diabetes, help may already be here in the form of the daily or weekly dosed glucagon-like-peptide-1 receptor agonists exenatide (Byetta, Bydureon), liraglutide (Victoza), dulaglutide (Trulicity), albiglutide (Tanzeum), and the amylin analog pramlintide acetate (Symlin). The U.S. Food and Drug Administration approved the first drugs in these two classes, exenatide and pramlintide, in 2005. Liraglutide was approved in 2010, extended-release exenatide in 2013, and dulaglutide and albiglutide in 2014. Beneficial effects, including weight loss, have led to the subsequent approval of liraglutide (Saxenda) for the treatment of obesity with or without diabetes. Many nurses, dietitians, advanced practitioners, and physicians who work with patients with diabetes have the responsibility of prescribing, educating, and monitoring patients who are using these important treatments.

Objectives:

The goal of this continuing education program is to enhance nurses’, dietitians’, advanced practitioners’, and physicians’ ability to care for patients taking new injectable classifications of medications for diabetes. After studying the information presented here, you will be able to:
  • Describe the roles of amylin and the human incretin hormone glucagon-like peptide-1 in regulating blood glucose levels
  • Explain three benefits of GLP-1 receptor agonists and amylin analog injection therapy
  • Discuss three nursing interventions to help patients adjust to and properly use GLP-1 receptor agonists or amylin analog therapy
 

 
Approval Information
 
This course is intended for multiple professions, including physicians, nurses, dietitians and dietary managers, and health educators.
 
Physicians: Take this version of the course to ensure you receive appropriate credit.
 
For the version accredited or approved for another profession, go to your specific profession at www.ContinuingEducation.com. If you have a CE Direct login ID and password (generally provided by your employer), please log in as you normally would at CEDirect.ContinuingEducation.com and search for this topic title.
 
Jointly Accredited Provider logoIn support of improving patient care, OnCourse Learning (a Relias LLC company) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 
OnCourse Learning is also approved by the Florida Board of Medicine and the Florida Board of Osteopathic Medicine (provider # FBN 50-1489).
 
Physician Continuing Education Credit
 
OnCourse Learning designates this enduring activity for a maximum of 1.0 AMA PRA category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
 
Physician Assistant Continuing Education Credit
 
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.0 hour of Category I credit for completing this program.
 
Disclosures
 
There is no commercial support provided for this online educational activity.

Course Originally Released on: 8/15/2012
Date of Most Recent Review: 4/25/2018
Course Termination/Update Date: 4/25/2021

Unless stated above, the planners and authors of this course have declared no relevant conflicts of interest that relate to this educational activity. Relias LLC guarantees this educational activity is free from bias.

Please see CE Course Instructions to learn how to earn CE credit for this module.

 

For Florida professionals:

This course completion will be electronically reported to CE Broker as required per Florida Statute 456.025(7). Click here to view your CE Broker transcript and check the status of your CE requirements with a FREE 7-day CE Broker trial subscription. It may take up to 24 hours for the course to appear on your CE Broker transcript.

It is now required that all CE is completed and reported to CE Broker before you renew your license. When you complete continuing education with us, OnCourse Learning will report your hours for you.

Read more about the new license renewal process at AreYouRenewalReady.com and claim your free Basic Account in CE Broker to see what has already been reported for you.

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid FL license number. This information is required for correct reporting of your course completions to CE Broker.

Reports to CE Broker

Sort By
Mary B - Blackwell, OK  ·  Sep 15, 2019
Well written course, easy to understand without being weighed down with too much added detail not needed to make the point.
Was this review helpful?  0
 
Elysia B - La Puente, CA  ·  Jun 18, 2019
Great topic, lots of information
Was this review helpful?  0
 
Myra D - Pearland, TX  ·  Jun 03, 2019
It was very educational.
Was this review helpful?  0
 
Frank A - Palm Coast, FL  ·  Jan 29, 2019
Very good information
Was this review helpful?  0
 
Auxilia C - Bear, DE  ·  Jan 27, 2019
good content, appropriate content
Was this review helpful?  0
 
  Page: of 13  
ONLINE
Price: $15.00
CE-PRO Price: $7.50